Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Outcomes showed that HRS9531 effectively reduced body weight, blood pressure, blood glucose, and triglycerides, with a favourable safety profile consistent with other GLP-1 agonists
GLP-1 receptor agonists have shown promise in addressing these issues, not only by managing diabetes and reducing cardiovascular risks but also by potentially lowering the risks of dementia and obesity-related cancers
doi: 10.1038/s41385021-004333 2 NgSCTangWChingJYWongMChowCMHuiAJet al
Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus
Few details are available so far, and CMS notes that more information will accompany future rulemaking
US$ 22.91
US$ 27.64
US$ 21.28
